|
Volumn 17, Issue 15, 2003, Pages 2325-2327
|
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives in MAPK-dependent amyloid precursor protein processing
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINE;
AMYLOID PRECURSOR PROTEIN;
MITOGEN ACTIVATED PROTEIN KINASE;
MONOAMINE OXIDASE B INHIBITOR;
NEUROTOXIN;
PROPARGYLAMINE;
RASAGILINE;
UNCLASSIFIED DRUG;
ALPHA SAPP PROTEIN, HUMAN;
ALPHA-SAPP PROTEIN, HUMAN;
AMYLOID BETA PROTEIN;
AMYLOID BETA PROTEIN (1 42);
AMYLOID BETA-PROTEIN (1-42);
ANTIPARKINSON AGENT;
DRUG DERIVATIVE;
INDAN DERIVATIVE;
NEUROPROTECTIVE AGENT;
PARGYLINE;
PEPTIDE FRAGMENT;
PROPYLAMINE;
ANIMAL CELL;
APOPTOSIS;
ARTICLE;
CELL DEATH;
CELL VIABILITY;
DERIVATIZATION;
DRUG EFFECT;
ENZYME ACTIVATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
NEUROPROTECTION;
NONHUMAN;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN PROCESSING;
ANIMAL;
BIOLOGICAL MODEL;
CELL STRAIN;
CHEMISTRY;
METABOLISM;
RAT;
SIGNAL TRANSDUCTION;
STRUCTURE ACTIVITY RELATION;
TUMOR CELL LINE;
ANIMALIA;
AMYLOID BETA-PROTEIN;
AMYLOID BETA-PROTEIN PRECURSOR;
ANIMALS;
ANTIPARKINSON AGENTS;
CELL LINE, TUMOR;
INDANS;
MAP KINASE SIGNALING SYSTEM;
MITOGEN-ACTIVATED PROTEIN KINASES;
MODELS, BIOLOGICAL;
NEUROPROTECTIVE AGENTS;
PARGYLINE;
PC12 CELLS;
PEPTIDE FRAGMENTS;
PROPYLAMINES;
PROTEIN PROCESSING, POST-TRANSLATIONAL;
RATS;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 0642303109
PISSN: 08926638
EISSN: None
Source Type: Journal
DOI: 10.1096/fj.03-0078fje Document Type: Article |
Times cited : (121)
|
References (0)
|